![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19811-19816, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 1, 2002
Formamidopyrimidine-DNA glycosylase (Fpg) is a
DNA repair enzyme that excises oxidized purines from damaged DNA. The
Schiff base intermediate formed during this reaction between
Escherichia coli Fpg and DNA was trapped by reduction with
sodium borohydride, and the structure of the resulting covalently
cross-linked complex was determined at a 2.1-Å resolution. Fpg is a
bilobal protein with a wide, positively charged DNA-binding groove. It
possesses a conserved zinc finger and a helix-two turn-helix motif that participate in DNA binding. The absolutely conserved residues Lys-56,
His-70, Asn-168, and Arg-258 form hydrogen bonds to the phosphodiester
backbone of DNA, which is sharply kinked at the lesion site.
Residues Met-73, Arg-109, and Phe-110 are inserted into the DNA
helix, filling the void created by nucleotide eversion. A deep
hydrophobic pocket in the active site is positioned to accommodate an
everted base. Structural analysis of the Fpg-DNA complex reveals
essential features of damage recognition and the catalytic mechanism of Fpg.
Oxidative DNA damage is generated by a variety of environmental
and endogenous agents, including ionizing radiation, certain chemicals,
and products of aerobic metabolism (1).
8-oxoG1 is one of the most
abundant forms of oxidative DNA damage (2). Due to its ability to form
a Hoogstein-type base pair with adenine (3), 8-oxoG is miscoding (4)
and mutagenic, resulting in G Fpg shares significant sequence homology with endonuclease VIII (Nei)
of E. coli (12). Both proteins belong to a family unrelated
by sequence or tertiary structure to a larger family of DNA
glycosylases, for which the prototype is endonuclease III (Nth) (13,
14). The substrate specificity of Fpg differs significantly from Nei
(7, 8, 15) but closely resembles that of the eukaryotic
8-oxoguanine-DNA glycosylase, Ogg1, a member of the Nth family (14, 16,
17). Fpg also possesses AP lyase activity, nicking the
phosphodiester backbone of DNA at the site of the lesion. Base excision
by Fpg is followed immediately by two Comparing the structures of Fpg, Nei, and Ogg1 provides a unique
opportunity to analyze features of damage recognition and catalysis
common to DNA glycosylases/AP lyases. The presence of DNA enhances the
analytic power of the model by revealing the precise nature of
enzyme-DNA interactions. The structure of the human Ogg1 catalytic
domain complexed to DNA has been solved (21, 22), as has the structure
of E. coli Nei covalently cross-linked to DNA by
NaBH4 (23). The structure of Fpg from Thermus
thermophilus HB8 (Tth-Fpg) has recently been solved in the absence
of DNA (24). Although mechanisms for lesion recognition and catalysis
by Fpg have been suggested on the basis of this structure and on
earlier biochemical studies of E. coli Fpg (8, 18, 24, 25),
many questions remain unanswered regarding the mode of Fpg-DNA
interactions and the catalytic reaction mechanism of this important DNA
repair protein.
To investigate the mechanisms of Fpg-DNA interactions, we have utilized
NaBH4 reduction of the Schiff base intermediate to produce
a stable covalent cross-link between Fpg and duplex DNA. We
crystallized and determined the three-dimensional structure of this
complex at 2.1 Å, revealing for the first time the three dimensional
precise mode of DNA binding by Fpg as well as several important
features of the catalytic mechanism of this enzyme. We used this model
to rationalize numerous biochemical observations and site-directed
mutagenesis studies of Fpg. The present study provides insight into the
structural basis of Fpg-DNA binding, furnishing information essential
for a mechanistic understanding of DNA glycosylases.
Oligonucleotides and Enzymes--
The 13-mers
CCAGGA(8-oxoG)GAAGCC and GGCTTCATCCTGG were synthesized by
established phosphoramidite chemistry (26) and annealed in a 1:1 ratio.
The E. coli fpg gene was amplified from E. coli genomic DNA by PCR using Pfu DNA polymerase
(Stratagene); NdeI and BamHI restriction sites
were present on the primers. The amplified fragment was inserted into
the NdeI-BamHI site of the pET13a plasmid (27)
and used to transform B834(DE3) E. coli cells. To purify recombinant Fpg, cells from 1 liter of culture, induced with 50 µM isopropyl-1-thio- Preparation of the Fpg-DNA Covalent Complex--
The
cross-linking reaction mixture (10 ml), including 100-200 nmol of
duplex oligonucleotide, 1-2 mg of Fpg, 25 mM sodium phosphate, pH 6.8, 100 mM NaCl, 1 mM EDTA, and
50 mM NaBH4 was incubated for 30 min at
37 °C and then quenched by adding 400 mM glucose. The
sample was loaded onto a Poros HQ 4.6/50 column (PerSeptive Biosystems)
equilibrated in 50 mM Tris-HCl, 5 mM
MgCl2, 200 mM NaCl, eluted at 460 mM NaCl, concentrated to 1.8-2.0 mg/ml in a Centricon-3
device (Millipore), and used for crystallization experiments.
Crystallization and Data Collection--
Crystals were obtained
by mixing 2-µl volumes of Fpg-DNA complex and reservoir solution
(30% (w/v) polyethylene glycol 8000, 0.2 M
(NH4)2SO4, 0.1 M sodium
cacodylate pH 6.5), and equilibrating the drop with 1 ml of reservoir
solution at 15 °C for several days. X-ray diffraction data (Table
I) were collected on crystals soaked for
~3 min in a solution composed of 80% reservoir solution, 20%
glycerol and flash-cooled to 100 K under a cold nitrogen gas stream.
Data were obtained with a Quantum-4 CCD area detector (ADSC) at the
National Synchroton Light Source X26C beamline, Brookhaven
National Laboratory, and processed with DENZO and SCALEPACK (28).
Structure Determination--
Matthews coefficient calculations
suggest four Fpg-DNA monomers in an asymmetric unit. The Fpg-DNA
structure was determined by molecular replacement (MR), using REPLACE
(29, 30) and CNS (31). Polar angle self-rotation function calculations
resulted in two major peaks, indicating an asymmetric unit of 222 non-crystallographic symmetry. Rotation and translation functions
calculations employed all data in the 10.0-4.0-Å resolution range.
Structures of Tth-Fpg (24) (1EE8) and a recently determined Nei-DNA
complex (Ref. 23, 1K3W) were combined to form a search model for MR.
Calculations imposing non-crystallographic symmetry, implemented in the
"locked" cross rotation function in REPLACE, resulted in clear
separation between the top and the second peaks, with no overlap
between monomers in the unit cell. A translation function search was
performed with CNS, using the constructed Fpg-DNA tetramer as a search
model and including Patterson correlation refinement (32) and rigid body refinement for each of the monomers. This search gave a clear MR
solution that was used for later stages of refinement. Solvent flipping
(33) and 4-fold averaging, calculated to 2.1 Å resolution, increased
the overall figure of merit from 0.42 to 0.89.
Electron density maps were calculated from the refined MR phases. An
initial model was constructed using the program "O" (34), allowing
clear determination of most of the structure, including components
(e.g. zinc ion and most of the DNA bases) missing from the
search model. The model was subjected to simulated annealing and
iterative cycles of positional and temperature factor refinement, followed by manual fitting and rebuilding. An overall anisotropic temperature factor and bulk solvent correction factor were applied throughout the calculation. Progress of the refinement was monitored via Rfree (35). Strict non-crystallographic
symmetry constraints were applied in the initial rounds of refinement.
Subsequently, tight non-crystallographic symmetry restraints (force
constant of 300 kcal/mol) were applied to allow proper refinement of
regions significantly different in structure from that of the search
model. All of the DNA and most of the protein residues were identified, except for the loop including residues 217-224 and the side chains of
several amino acids remote from the protein-DNA interface. Water
molecules were assigned to peaks in the [Fo Molecular Modeling and Conservation Analysis--
A model of Fpg
complexed with the DNA duplex containing an everted 8-oxodG residue was
built based on the current structure and the structure of
8-oxoG-containing DNA from the Ogg1-DNA complex (1EBM, Ref. 21). The
missing residues 217-224 were modeled based on the corresponding loop
of Tth-Fpg (1EE8, Ref. 24). The model was subjected to a series of
energy minimization steps using the Discover module of Insight II
(Accelrys) until the root mean-squared gradient was smaller than 0.001 kcal/(mol·Å). All energy optimizations were performed using the
AMBER force field (42) with a distance-dependent dielectric
constant of 4r, using the steepest descent and conjugate gradient
methods. The phosphorus atoms of the DNA and the C Overall Structure--
The overall structure of Fpg comprises two
domains connected by a hinge polypeptide (Fig.
1, a and b) and
resembles that of Tth-Fpg (24) and E. coli Nei (23). The
N-terminal domain contains eight
The excised base, 8-oxoG, is not retained in the crystal. The
ring-opened deoxyribitol moiety (dRbl), formed after base excision and
NaBH4 reduction, is everted from the helix with C1' bound covalently to N Fpg-DNA Interactions--
Binding to DNA involves extensive
interactions between Fpg and DNA (Fig.
4). A hydrogen bond network involving all
loops that face DNA comprises 2512 Å2 of contact surface
area. This relatively large buried surface area is consistent with the
heat capacity change reported for Fpg binding to a lesion-containing
duplex.2 A similar value for
binding-induced burial of previously exposed solvent accessible surface
area (2268 Å2) has been reported for Ogg1 (21);
significantly higher than for human alkylpurine-DNA glycosylase
(1034 Å2) (45) and uracil-DNA glycosylase (700 Å2) (46).
Fpg mainly contacts the damaged strand 3' to dRbl (P0,
P
Asn-168, Arg-258, and Lys-56 contact P0, P Interactions at the Lesion Site--
Extrusion of the damaged
base, which facilitates its binding in the enzyme active site, is a
common structural feature of DNA glycosylases (21, 45, 47, 48).
Eversion of deoxyribose is achieved by rotation around the P-O5' and
O3'-P bonds. The geometry of Fpg-induced DNA kinking differs from that
observed for uracil-DNA glycosylase (46, 47) and Ogg1 (21), which "pinch" the DNA backbone at the extrusion site, decreasing the normal distance (~12 Å in B-DNA) between P
Eversion of dRb1, coupled with loss of a base, creates a
substantial gap between opposite strands, reflected in the 14.7 Å distance between C1' of dRb1 and C(0), as compared with
10.5 Å in B-DNA. The gap is filled by the hydrophobic residues Met-73,
Arg-108, and Phe-110 (Fig. 5b). Met-73, part of the
The position of dRb1 is fixed by the N 8-OxoG-binding Site--
A deep binding pocket for the everted
base formed by Pro-1, Glu-2, Glu-5, Ile-169, Tyr-170, Thr-214, Thr-215,
and Leu-216 is clearly visible (Fig. 3); however, the excised 8-oxoG
base could not be located in our electron density maps. We searched for
the site of 8-oxoG binding using two independent approaches. Computer
simulation involving energy minimization and molecular dynamics,
with 8-oxoG and the 217-224 loop modeled in the structure, suggested
this site for the 8-oxoG-binding pocket. When the 217-224 loop is
present, the side chain of Lys-217 closes the pocket, extending along
the Hoogstein face of 8-oxoG and isolating it from the solvent. This
conformation places N
In addition, we analyzed conservation of amino acid residues in the Fpg
family, which can be divided into Fpg and Nei subfamilies (54). At some
positions, residues are highly conserved within the Fpg subfamily but
not within the Nei subfamily. Alternatively, they may be conserved
within the Nei subfamily but differ significantly in their
physicochemical properties from residues at the respective positions of
Fpg subfamily members. Such "dissimilar" residues may be important
for functions specific to the Fpg subfamily, the most obvious of which
is substrate specificity. When dissimilar residues are mapped on the
surface of Fpg, several of them (Glu-5, Ile-169, Tyr-170) fall into the
pocket identified by modeling, suggesting the importance of this region
for 8-oxoG-specific recognition.
Mechanistic Implications--
The present structure may be used to
rationalize the wealth of biochemical data accumulated for Fpg (53,
55). Pro-1 and Glu-2 are critical for base release in the Fpg-catalyzed
reaction. During the consecutive
Peptide mapping, site-directed mutagenesis, and mass spectrometric
experiments established Pro-1 as the site of Schiff base formation (18,
19). The Fpg-DNA structure confirms that Pro-1 N
Mutations of conserved glutamates Glu-2, Glu-5, Glu-131, and Glu-173 to
glutamines decrease the glycosylase but not the AP lyase activity of
Fpg (52). Glu-2 stabilizes and protonates O4' of dRbl (Fig.
6a) and may activate Pro-1 for nucleophilic attack
((Glu-2)O
Lys-56 and Lys-154 have been implicated in substrate specificity.
Mutations K56G, K56R, and K154A reduce the efficiency of Fpg acting on
substrates containing 8-oxoG but not on DNA containing Me-FaPy or AP
sites (25, 60). These conserved residues participate in a
hydrogen-bonding network near dRbl, with Lys-56 contacting P
DNA binding by Fpg is abolished by mutation of any of the four
cysteines in the zinc finger (61, 62). This motif exists as a separate
subdomain, and its disruption would not affect overall folding,
consistent with circular dichroism data (61), but would create
conformational changes that affect positioning of the conserved Arg-258. In the zinc finger mutants, AP lyase activity is affected less
than base excision activity (62), consistent with our observation that
mutation of the homologous Arg-252 in Nei inactivates glycosylase, but
not AP lyase activity (23). Cysteines 146 and 194 are remote from the
active site and when mutated have little effect on enzymatic function
(62).
In conclusion, the crystal structure of Fpg cross-linked to duplex DNA
reveals the mode of substrate binding for this important family of DNA
glycosylases and identifies highly conserved active site residues
involved in the catalytic action of this enzyme. The structural data
presented here clarify many of the biochemical properties reported for
Fpg. They provide insights into the nature of protein-nucleic acid
interactions and facilitate our understanding of mechanisms of base
excision repair.
We thank Cecilia Torres for preparing the
oligonucleotides used in this study, Erich Bremer for help in preparing
images, and Dr. Dieter Schneider for expert assistance in collecting
data on the X26C beamline at NSLS.
*
This investigation was supported by Research Grants CA-17395
and CA-47995 (to A. P. G.) from the National Institutes of Health. Work at Brookhaven National Laboratories was supported by the office of
Biological and Environmental Research of the United States Department
of Energy.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1K82) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
These individuals contributed equally to this work.
**
A recipient of Grant 02-04-49605 from the Russian Foundation for
Basic Research.
§§
To whom correspondence should be addressed. Tel.: 631-444-3080;
Fax: 631-444-7641; E-mail: apg@pharm.sunysb.edu.
Published, JBC Papers in Press, March 23, 2002, DOI 10.1074/jbc.M202058200
2
C. A. Minetti, D. P. Remeter, E. G. Plum,
and K. J. Breslauer, unpublished observations.
The abbreviations used are:
8-oxoG, 8-oxo-7,8-dihydroguanine;
8-oxodG, 8-oxo-7,8-dihydro-2'-deoxyguanosine;
dRbl, deoxyribitol;
Tth-Fpg, Thermus thermophilus
formamidopyrimidine-DNA glycosylase;
H2TH, helix-two turn-helix motif;
Me-FaPy, 2,6-diamino-4-hydroxy-5N-methylformamidopyrimidine;
MR, molecular replacement, Nei, endonuclease VIII;
Nth, endonuclease
III;
Ogg1, 8-oxoguanine-DNA glycosylase;
AP, apurinic/apyrimidinic.
Structure of Formamidopyrimidine-DNA Glycosylase
Covalently Complexed to DNA*
§,
**,
,
,
,
,
Department of Inorganic Chemistry and the
Laboratory for Structural Chemistry and Biology, The Hebrew University
of Jerusalem, Jerusalem 91904, Israel, the ¶ Laboratory of
Chemical Biology, Department of Pharmacological Sciences, State
University of New York, Stony Brook, New York 11794, the
Novosibirsk Institute of Bioorganic Chemistry, Siberian Division
of Russian Academy of Sciences, Novosibirsk 630090, Russia, and the

Department of Biology, Brookhaven National
Laboratories, Upton, New York 11973
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
T transversions in bacterial and
eukaryotic cells (5, 6). The potential harmful effects of this lesion
are avoided by base excision repair. In Escherichia coli,
formamidopyrimidine-DNA glycosylase (Fpg, EC 3.2.2.23) removes 8-oxoG,
Me-FaPy, and several structurally related lesions from damaged
DNA (7, 8). Fpg is a component of the "GO system" that includes
MutY, a mismatch adenine-DNA glycosylase, and MutT, an 8-oxodGTPase (9,
10); E. coli strains deficient in any of these genes are
strong mutators (11).
-elimination steps, resulting
in a single nucleotide gap flanked by phosphate termini (7). A Schiff
base intermediate, involving Pro-1 of the enzyme and C1' of the damaged
nucleotide, forms early in the reaction sequence and can be reductively
trapped by treatment with NaBH4 forming a stable covalent
complex (18, 19). The mechanism of cleavage is similar to that of Nei
(15, 20), but not to that of Ogg1 where only one
-elimination
occurs, and the efficiency of the elimination step is very low compared
with base excision (16, 17).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-D-galactopyranoside
for 6 h at 37 °C, were lysed by treatment with 50 µg/ml
lysozyme in Tris/EDTA buffer, pH 8.0, containing 1 mM
phenylmethylsulfonyl fluoride. DNA was precipitated with 0.01%
polyethyleneimine, 1 M NaCl, and the supernatant was
treated with 45% saturated
(NH4)2SO4. The pellet was dissolved in Buffer A (20 mM HEPES-NaOH, pH 7.5, 1 mM
EDTA, 1 mM dithiothreitol, 200 mM NaCl), loaded
on a Fractogel EMD SO
Crystallographic data collection and refinement parameters
Fc] electron density maps larger than 3
and
within potential hydrogen-bonding distance. The figures were prepared
using MidasPlus (36), MOLSCRIPT (37), BOBSCRIPT (38), Raster3D (39),
and GRASP (40). 3DNA (41) was used to calculate various DNA structural parameters.
atoms of the
protein, except for the newly built loop, were restrained with harmonic
forces. To find a conformation with lower energy for the missing loop
and the everted 8-oxodG, we also performed simulated annealing
molecular dynamic runs from 1000 to 298 K. The conservation of residues
within the Nei and Fpg subfamilies of the Fpg family was analyzed using
the AMAS algorithm (43) and the cluster of orthologous groups data base
(44), as described elsewhere (23).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-strands, forming a
-sandwich
with two
-helices parallel to its edges. The C-terminal domain
includes four
-helices, two of which,
D and
E, form the
helix-two turn-helix (H2TH) motif, and two
-strands that form a
-hairpin zinc finger.

View larger version (41K):
[in a new window]
Fig. 1.
Overall structure of Fpg-DNA.
a, view perpendicular to the long axis of Fpg, demonstrating
the DNA binding cleft. The N-terminal domain is shown in
green, the interdomain hinge in red, and the
C-terminal domain in blue, except for the H2TH
(purple) and zinc finger (cyan) motifs. The zinc
atom is represented by a gray ball and the covalently linked
Pro-1 is highlighted is cyan. The DNA backbone is colored
orange and bases in yellow. b, view
approximately orthogonal to a, highlighting the protein-DNA
contact area and the DNA kink.
of Pro-1 (Fig. 2), as
suggested by biochemical experiments identifying Pro-1 as the residue
involved in Schiff base formation (18, 19). DNA is severely kinked at
the lesion point (roll angle, 66°), and the minor groove is
significantly widened. Except at the lesion site, the DNA is
essentially B-form. As commonly observed in DNA-binding proteins, the
DNA-binding groove is positively charged (Fig.
3).

View larger version (77K):
[in a new window]
Fig. 2.
Experimental electron density map
([2Fo
Fc] coefficients at
3.0
contour level) around the dRbl-Pro-1
region, demonstrating clarity of the structure at 2.1 Å resolution. Note the Pro-1 N
-dRbl covalent bond and close
proximity of O
2 of Glu-2 to O4' of dRbl and of Lys-56 to
P
1 and P
2.

View larger version (85K):
[in a new window]
Fig. 3.
The solvent-accessible surface of Fpg,
colored according to electrostatic potential and demonstrating the
positive DNA binding cleft. The bound 13-mer DNA duplex is
superimposed on the positively charged surface as a stick
model (yellow). The negatively charged binding pocket
is clearly seen in the center of the groove, containing the modeled
8-oxoG (inset).

View larger version (29K):
[in a new window]
Fig. 4.
Schematic representation of Fpg-DNA
interactions. The central nucleotides of the modified and
complementary strands are 8-oxoG0 and C(0),
respectively. Nucleotides are numbered as shown with those in the
complementary strand in parentheses.
1, P
2) via side chains and backbone
hydrogen atoms of the highly conserved Lys-56, His-70, Asn-168,
Tyr-236, and Arg-258 residues. Fpg binds DNA in the minor groove; the
damaged base is extruded from the helix through the major groove (Fig.
3). The complementary strand is held in position largely through
Watson-Crick bonds; interactions with the enzyme are few, and except
for His-89, the amino acids involved are not conserved.
1,
and P
2, stabilizing the complex (Fig.
5a). Asn-168 is part of the
H2TH motif and forms bonds through backbone and side chain amides to
P
1 and P0, respectively. The zinc finger
forms four hydrogen bonds with the phosphodiester backbone, three of
which involve Arg-258 (two to P0, one to P
1)
and one via Gln-257, to P(3). Lys-56, located on the
2-
3 loop, forms hydrogen bonds with P
1 and
P
2.

View larger version (65K):
[in a new window]
Fig. 5.
Stereoview of specific interactions between
Fpg and DNA. a, interactions of protein residues with
DNA phosphates around the lesion. b, residues filling the
void in DNA, demonstrating the intrusion of Met-73 and the specific
interactions of Arg-108 with bases on both DNA strands. Protein side
chain carbons are shown in light green and the relevant
secondary structure elements in gray. DNA base carbons are
shown in dark green.
1 and
P1 by 30-50%. Similar to E. coli and human
alkylpurine-DNA glycosylases complexed with DNA (45, 48), Fpg does not
compress the phosphodiester backbone (P
1-P1
is 11.4 Å). Thus, base eversion is not absolutely dependent on strain
induced by massive backbone compression (46, 47). Nucleotide eversion
effected by Fpg may be achieved by "holding" the flanking phosphates with Lys-56, Asn-168, and Arg-258, coupled with
intercalation of hydrophobic residues into duplex DNA (49) (Fig. 5,
a and b). The energy required for extruding a
single base from kinked double helical DNA has been estimated at ~3
kcal/mol (50), a barrier readily attained through noncovalent
enzyme-DNA interactions.
4-
5 loop, enters the helix through the minor groove, occupying
the position vacated by the extruded base. Arg-108 and Phe-110 are
located on the
7-
8 loop. Phe-110, wedged between C(1)
and C(0), engages in face-to-face
interactions (51)
with the C(1) pyrimidine ring. Unstacking of these bases
may contribute significantly to DNA kinking. C(0) remains
intrahelical, stabilized by hydrogen bonds from O2 and N3 to Arg-108,
contributing to Fpg specificity through opposite base recognition (Fig.
5b).
-C1' covalent bond and the
absolutely conserved Glu-2, which forms a hydrogen bond with O4'. Glu-2
is stabilized by hydrogen bonds to backbone amides of Ile-169 and
Gly-167 located in the H2TH
E helix. Because the E2Q mutation
inactivates the glycosylase activity of Fpg, but does not affect its AP
lyase activity (52), Glu-2 probably is involved in protonation of O4'
during base excision (53) (Fig. 6a).

View larger version (13K):
[in a new window]
Fig. 6.
Scheme of principal steps in the sequence of
reactions catalyzed by Fpg, showing catalytically important amino acid
residues. Nucleophilic attack at C1' and protonation at O4'
(a) lead to base displacement and deoxyribose ring opening.
A Schiff base involving Pro-1 is formed with O4' stabilized by hydrogen
bonding to Glu-2. b, following abstraction of the 2' proton
of deoxyribose by a general base, Lys-56 protonates the 3'-phosphate
leading to
-elimination (c). Deprotonation of C4', now
vinilogous to C1', is followed by protonation of the 5'-phosphate by
Arg-258 and the second
-elimination event (c).
of Lys-217 in the proximity of 8-oxoG N7 and
O8 atoms [N
(Lys-217)-N7(8-oxoG), 3.56 Å;
N
(Lys-217)-O8(8-oxoG), 3.39 Å], making Lys-217 an ideal moiety for the recognition of the 8-oxoG lesion.
-elimination steps that follow
(56), Fpg must protonate the leaving phosphates. Lys-56 and Arg-258 are
well positioned to protonate P
1 and P0,
respectively (Fig. 6, b and c). Following
elimination of P
1, its contact with Arg-258 may be
relaxed, allowing this residue to move closer to P0 for
more efficient protonation. Surprisingly, the conformation of dRbl in
the catalytic intermediate is inconsistent with the syn
stereochemistry of pro-S-2' hydrogen abstraction proposed for other AP
lyases (57, 58), suggesting an anti stereochemical course.
is covalently bound
to C1'. Fluorescence experiments suggest that the structure of P1E Fpg
is more rigid than that of wild type Fpg and P1G and K56G mutants (59).
Pro-1 lies at the head of a long helix
A, which in addition to a
standard dipole moment has acidic N-terminal and basic C-terminal
halves. P1E mutation further increases dipole moment, strengthening
electrostatic interactions with Lys-56 and Arg-258 and tightening the
protein globule.
2-N
(Pro-1), 5.71 Å). Glu-5, which moderates Fpg
activity, may help orient Glu-2 for catalysis via interaction with its
backbone amide. In addition, Glu-2 and Glu-5 participate in forming the
8-oxoG-binding pocket. Glu-131 forms hydrogen bonds to Arg-53, Arg-54,
and Ala-55, stabilizing the
2-
3 loop and bringing together the N-
and C-terminal domains; loss of these interactions would affect
positioning of Lys-56. Glu-173 forms hydrogen bonds with the backbone
amides of Gln-234, Val-235, and Tyr-236, stabilizing the turn formed by
these residues. This turn, together with the edge-to-face interaction
(51) with Phe-261, helps orient Tyr-236, which donates a hydrogen bond
to P0. Hydrogen bonding by these Glu residues is modified
upon mutation to Gln. In contrast, conversion of the conserved Asp-106
and Asp-159 residues to Asn retains hydrogen bonding capability; these
mutations do not affect Fpg activity (52).
1 and P
2 and Lys-154 forming a strong
hydrogen bond to O
1 of Asn-168. Nucleotide eversion moves the
position of C1' away from these residues, making it unlikely that they
will participate in recognition of the damaged base. However, Me-FaPy
is less stable than 8-oxoG to acid-catalyzed depurination and
protonation of the base; alternatively, protonation of O4' may be
sufficient to break the glycosidic bond of this lesion. The resulting
AP site would be less sensitive to the loss of Lys-56 or Lys-154 due to
spontaneous opening of the deoxyribose ring, which relaxes the
requirement for strict positioning of C1' for nucleophilic attack
(23).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1.
von Sonntag, C.
(1987)
The Chemical Basis of Radiation Biology
, Taylor & Francis, London
2.
Burrows, C. J.,
and Muller, J. G.
(1998)
Chem. Rev.
98,
1109-1151[CrossRef][Medline]
[Order article via Infotrieve]
3.
Kouchakdjian, M.,
Bodepudi, V.,
Shibutani, S.,
Eisenberg, M.,
Johnson, F.,
Grollman, A. P.,
and Patel, D. J.
(1991)
Biochemistry
30,
1403-1412[CrossRef][Medline]
[Order article via Infotrieve]
4.
Shibutani, S.,
Takeshita, M.,
and Grollman, A. P.
(1991)
Nature
349,
431-434[CrossRef][Medline]
[Order article via Infotrieve]
5.
Moriya, M., Ou, C.,
Bodepudi, V.,
Johnson, F.,
Takeshita, M.,
and Grollman, A. P.
(1991)
Mutat. Res.
254,
281-288[Medline]
[Order article via Infotrieve]
6.
Moriya, M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
1122-1126 7.
Tchou, J.,
Kasai, H.,
Shibutani, S.,
Chung, M.-H.,
Laval, J.,
Grollman, A. P.,
and Nishimura, S.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4690-4694 8.
Tchou, J.,
Bodepudi, V.,
Shibutani, S.,
Antoshechkin, I.,
Miller, J.,
Grollman, A. P.,
and Johnson, F.
(1994)
J. Biol. Chem.
269,
15318-15324 9.
Michaels, M. L.,
Tchou, J.,
Grollman, A. P.,
and Miller, J. H.
(1992)
Biochemistry
31,
10964-10968[CrossRef][Medline]
[Order article via Infotrieve]
10.
Michaels, M. L.,
and Miller, J. H.
(1992)
J. Bacteriol.
174,
6321-6325 11.
Tajiri, T.,
Maki, H.,
and Sekiguchi, M.
(1995)
Mutat. Res.
336,
257-267[Medline]
[Order article via Infotrieve]
12.
Jiang, D.,
Hatahet, Z.,
Blaisdell, J. O.,
Melamede, R. J.,
and Wallace, S. S.
(1997)
J. Bacteriol.
179,
3773-3782 13.
Thayer, M. M.,
Ahern, H.,
Xing, D.,
Cunningham, R. P.,
and Tainer, J. A.
(1995)
EMBO J.
14,
4108-4120[Medline]
[Order article via Infotrieve]
14.
Nash, H. M.,
Bruner, S. D.,
Shärer, O. D.,
Kawate, T.,
Addona, T. A.,
Spooner, E.,
Lane, W. S.,
and Verdine, G. L.
(1996)
Curr. Biol.
6,
968-980[CrossRef][Medline]
[Order article via Infotrieve]
15.
Jiang, D.,
Hatahet, Z.,
Melamede, R. J.,
Kow, Y. W.,
and Wallace, S. S.
(1997)
J. Biol. Chem.
272,
32230-32239 16.
Rosenquist, T. A.,
Zharkov, D. O.,
and Grollman, A. P.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7429-7434 17.
Zharkov, D. O.,
Rosenquist, T. A.,
Gerchman, S. E.,
and Grollman, A. P.
(2000)
J. Biol. Chem.
275,
28607-28617 18.
Tchou, J.,
and Grollman, A. P.
(1995)
J. Biol. Chem.
270,
11671-11677 19.
Zharkov, D. O.,
Rieger, R. A.,
Iden, C. R.,
and Grollman, A. P.
(1997)
J. Biol. Chem.
272,
5335-5341 20.
Rieger, R. A.,
McTigue, M. M.,
Kycia, J. H.,
Gerchman, S. E.,
Grollman, A. P.,
and Iden, C. R.
(2000)
J. Am. Soc. Mass Spectrom.
11,
505-515[CrossRef][Medline]
[Order article via Infotrieve]
21.
Bruner, S. D.,
Norman, D. P. G.,
and Verdine, G. L.
(2000)
Nature
403,
859-866[CrossRef][Medline]
[Order article via Infotrieve]
22.
Norman, D. P. G.,
Bruner, S. D.,
and Verdine, G. L.
(2001)
J. Am. Chem. Soc.
123,
359-360[CrossRef][Medline]
[Order article via Infotrieve]
23.
Zharkov, D. O.,
Golan, G.,
Gilboa, R.,
Fernandes, A. S.,
Gerchman, S. E.,
Kycia, J. H.,
Rieger, R. A.,
Grollman, A. P.,
and Shoham, G.
(2002)
EMBO J.
23,
789-800[CrossRef]
24.
Sugahara, M.,
Mikawa, T.,
Kumasaka, T.,
Yamamoto, M.,
Kato, R.,
Fukuyama, K.,
Inoue, Y.,
and Kuramitsu, S.
(2000)
EMBO J.
19,
3857-3869[CrossRef][Medline]
[Order article via Infotrieve]
25.
Rabow, L. E.,
and Kow, Y. W.
(1997)
Biochemistry
36,
5084-5096[CrossRef][Medline]
[Order article via Infotrieve]
26.
Bodepudi, V.,
Shibutani, S.,
and Johnson, F.
(1992)
Chem. Res. Toxicol.
5,
608-617[CrossRef][Medline]
[Order article via Infotrieve]
27.
Gerchman, S. E.,
Graziano, V.,
and Ramakrishnan, V.
(1994)
Protein Expr. Purif.
5,
242-251[CrossRef][Medline]
[Order article via Infotrieve]
28.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
29.
Tong, L.,
and Rossmann, M. G.
(1990)
Acta Crystallogr.
A46,
783-792
30.
Tong, L.
(1993)
J. Appl. Crystallogr.
26,
748-751
31.
Brünger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr.
D54,
905-921
32.
Brünger, A. T.
(1990)
Acta Crystallogr.
A46,
46-57
33.
Abrahams, J. P.,
and Leslie, A. G. W.
(1996)
Acta Crystallogr.
D52,
30-42
34.
Jones, T. A.,
Zou, J.-Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr.
A47,
110-119
35.
Brünger, A. T.
(1992)
Nature
355,
472-475[CrossRef][Medline]
[Order article via Infotrieve]
36.
Ferrin, T. E.,
Huang, C. C.,
Jarvis, L. E.,
and Langridge, R.
(1988)
J. Mol. Graphics
6,
13[Medline]
[Order article via Infotrieve]- 27, 36-37
37.
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
38.
Esnouf, R. M.
(1997)
J. Mol. Graphics
15,
132-134[CrossRef]
39.
Merrit, E. A.,
and Bacon, D. J.
(1997)
Methods Enzymol.
277,
505-524[Medline]
[Order article via Infotrieve]
40.
Nicholls, A.,
Sharp, K. A.,
and Honig, B.
(1991)
Proteins
11,
281-296[CrossRef][Medline]
[Order article via Infotrieve]
41.
Lu, X.-J.,
Shakked, Z.,
and Olson, W. K.
(2000)
J. Mol. Biol.
300,
819-840[CrossRef][Medline]
[Order article via Infotrieve]
42.
Weiner, S. J.,
Kollman, P. A.,
Case, D. A.,
Singh, U. C.,
Ghio, C.,
Alagona, G.,
Profeta, S., Jr.,
and Weiner, P.
(1984)
J. Am. Chem. Soc.
106,
765-784[CrossRef]
43.
Livingstone, C. D.,
and Barton, G. J.
(1993)
Comput. Appl. Biosci.
9,
745-756 44.
Tatusov, R. L.,
Natale, D. A.,
Garkavtsev, I. V.,
Tatusova, T. A.,
Shankavaram, U. T.,
Rao, B. S.,
Kiryutin, B.,
Galperin, M. Y.,
Fedorova, N. D.,
and Koonin, E. V.
(2001)
Nucleic Acids Res.
29,
22-28 45.
Lau, A. Y.,
Schärer, O. D.,
Samson, L.,
Verdine, G. L.,
and Ellenberger, T.
(1998)
Cell
95,
249-258[CrossRef][Medline]
[Order article via Infotrieve]
46.
Parikh, S. S.,
Mol, C. D.,
Slupphaug, G.,
Bharati, S.,
Krokan, H. E.,
and Tainer, J. A.
(1998)
EMBO J.
17,
5214-5226[CrossRef][Medline]
[Order article via Infotrieve]
47.
Slupphaug, G.,
Mol, C. D.,
Kavli, B.,
Arvai, A. S.,
Krokan, H. E.,
and Tainer, J. A.
(1996)
Nature
384,
87-92[CrossRef][Medline]
[Order article via Infotrieve]
48.
Hollis, T.,
Ichikawa, Y.,
and Ellenberger, T.
(2000)
EMBO J.
19,
758-766[CrossRef][Medline]
[Order article via Infotrieve]
49.
Werner, R. M.,
Jiang, Y. L.,
Gordley, R. G.,
Jagadeesh, G. J.,
Ladner, J. E.,
Xiao, G.,
Tordova, M.,
Gilliland, G. L.,
and Stivers, J. T.
(2000)
Biochemistry
39,
12585-12594[CrossRef][Medline]
[Order article via Infotrieve]
50.
van Aalten, D. M. F.,
Erlanson, D. A.,
Verdine, G. L.,
and Joshua-Tor, L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11809-11814 51.
Burley, S. K.,
and Petsko, G. A.
(1985)
Science
229,
23-28 52.
Lavrukhin, O. V.,
and Lloyd, R. S.
(2000)
Biochemistry
39,
15266-15271[CrossRef][Medline]
[Order article via Infotrieve]
53.
McCullough, A. K.,
Dodson, M. L.,
and Lloyd, R. S.
(1999)
Annu. Rev. Biochem.
68,
255-285[CrossRef][Medline]
[Order article via Infotrieve]
54.
Zharkov, D. O.,
and Grollman, A. P.
(2002)
Free Radic. Biol. Med.
32,
1254-1263
55.
David, S. S.,
and Williams, S. D.
(1998)
Chem. Rev.
98,
1221-1261[CrossRef][Medline]
[Order article via Infotrieve]
56.
Bhagwat, M.,
and Gerlt, J. A.
(1996)
Biochemistry
35,
659-665[CrossRef][Medline]
[Order article via Infotrieve]
57.
Mazumder, A.,
Gerlt, J. A.,
Rabow, L.,
Absalon, M. J.,
Stubbe, J.,
and Bolton, P. H.
(1989)
J. Am. Chem. Soc.
111,
8029-8030[CrossRef]
58.
Mazumder, A.,
Gerlt, J. A.,
Absalon, M. J.,
Stubbe, J.,
Cunningham, R. P.,
Withka, J.,
and Bolton, P. H.
(1991)
Biochemistry
30,
1119-1126[CrossRef][Medline]
[Order article via Infotrieve]
59.
Kuznetsov, S. V.,
Sidorkina, O. M.,
Jurado, J.,
Bazin, M.,
Tauc, P.,
Brochon, J.-C.,
Laval, J.,
and Santus, R.
(1998)
Eur. J. Biochem.
253,
413-420[Medline]
[Order article via Infotrieve]
60.
Sidorkina, O. M.,
and Laval, J.
(1998)
Nucleic Acids Res.
26,
5351-5357 61.
Tchou, J.,
Michaels, M. L.,
Miller, J. H.,
and Grollman, A. P.
(1993)
J. Biol. Chem.
268,
26738-26744 62.
O'Connor, T. R.,
Graves, R. J.,
de Murcia, G.,
Castaing, B.,
and Laval, J.
(1993)
J. Biol. Chem.
268,
9063-9070
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. A. S. A. Minetti, D. P. Remeta, and K. J. Breslauer A continuous hyperchromicity assay to characterize the kinetics and thermodynamics of DNA lesion recognition and base excision PNAS, January 8, 2008; 105(1): 70 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Couve-Privat, G. Mace, F. Rosselli, and M. K. Saparbaev Psoralen-induced DNA adducts are substrates for the base excision repair pathway in human cells Nucleic Acids Res., September 27, 2007; 35(17): 5672 - 5682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Baker, G. Wuenschell, L. Xia, J. Termini, S. E. Bates, A. D. Riggs, and T. R. O'Connor Nucleotide Excision Repair Eliminates Unique DNA-Protein Cross-links from Mammalian Cells J. Biol. Chem., August 3, 2007; 282(31): 22592 - 22604. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Blaisdell and S. S. Wallace Rapid determination of the active fraction of DNA repair glycosylases: a novel fluorescence assay for trapped intermediates Nucleic Acids Res., March 12, 2007; 35(5): 1601 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rogacheva, A. Ishchenko, M. Saparbaev, S. Kuznetsova, and V. Ogryzko High Resolution Characterization of Formamidopyrimidine-DNA Glycosylase Interaction with Its Substrate by Chemical Cross-linking and Mass Spectrometry Using Substrate Analogs J. Biol. Chem., October 27, 2006; 281(43): 32353 - 32365. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Buchko, C.-Y. Kim, T. C. Terwilliger, and M. A. Kennedy Solution Structure of the Conserved Hypothetical Protein Rv2302 from Mycobacterium tuberculosis. J. Bacteriol., August 1, 2006; 188(16): 5993 - 6001. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rieger, E. I. Zaika, W. Xie, F. Johnson, A. P. Grollman, C. R. Iden, and D. O. Zharkov Proteomic Approach to Identification of Proteins Reactive for Abasic Sites in DNA Mol. Cell. Proteomics, May 1, 2006; 5(5): 858 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banerjee, W. L. Santos, and G. L. Verdine Structure of a DNA glycosylase searching for lesions. Science, February 24, 2006; 311(5764): 1153 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. de Jesus, L. Serre, C. Zelwer, and B. Castaing Structural insights into abasic site for Fpg specific binding and catalysis: comparative high-resolution crystallographic studies of Fpg bound to various models of abasic site analogues-containing DNA Nucleic Acids Res., October 20, 2005; 33(18): 5936 - 5944. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Golan, D. O. Zharkov, H. Feinberg, A. S. Fernandes, E. I. Zaika, J. H. Kycia, A. P. Grollman, and G. Shoham Structure of the uncomplexed DNA repair enzyme endonuclease VIII indicates significant interdomain flexibility Nucleic Acids Res., September 6, 2005; 33(15): 5006 - 5016. [Abstract] |